Multicentric Single Arm Phase II Clinical Trial, to Evaluate Safety and Efficacy of the Combination of Olaparib and PLD for Platinum Resistant Ovarian Primary Peritoneal Carcinoma, and Fallopian Tube Cancer Patients.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Olaparib (Primary) ; Doxorubicin liposomal
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Acronyms ROLANDO
- 14 Nov 2017 Planned End Date changed from 1 Feb 2020 to 1 Jun 2020.
- 14 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
- 14 Nov 2017 Planned initiation date changed from 1 Jun 2017 to 1 Dec 2017.